• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Reversing the effects of the new anti-clotting drugs
The oral anticoagulant warfarin (Coumadin) became available for prescription in 1954. This anti-clotting drug commanded national attention when President Dwight Eisenhower received the drug as part of his treatment following a heart attack. No other oral anticoagulant was successfully developed and marketed in the United States until 2010. Warfarin is a dangerous drug. Along with insulin, it is responsible for the most emergency hospitalizations due to adverse drug reactions. Whereas insulin causes low blood sugar, warfarin is notorious for the complication of major bleeding. Warfarin is plagued by hundreds of drug-drug an...
Source: New Harvard Health Information - December 9, 2015 Category: Consumer Health News Authors: Samuel Z. Goldhaber, MD Tags: Drugs and Supplements Health Heart Health Hypertension and Stroke anti-clotting coumadin deep-vein-thrombosis DVT Source Type: news

Early-Phase NOAC, VKA Therapy: Similar Bleeding, Stroke Risk Early-Phase NOAC, VKA Therapy: Similar Bleeding, Stroke Risk
Thus, physicians must be just as cautious when initiating dabigatran or rivaroxaban as when initiating a vitamin-K agonist, the authors of this French nationwide cohort study say. Heartwire from Medscape
Source: Medscape Medical News Headlines - August 6, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news